Cargando…

UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays

INTRODUCTION: The fast, precise, and accurate measurement of the new generation of oral anticoagulants such as dabigatran and rivaroxaban in patients’ plasma my provide important information in different clinical circumstances such as in the case of suspicion of overdose, when patients switch from e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuhn, Joachim, Gripp, Tatjana, Flieder, Tobias, Dittrich, Marcus, Hendig, Doris, Busse, Jessica, Knabbe, Cornelius, Birschmann, Ingvild
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689546/ https://www.ncbi.nlm.nih.gov/pubmed/26699714 http://dx.doi.org/10.1371/journal.pone.0145478

Ejemplares similares

The Sysmex CS-5100 coagulation analyzer offers comparable analytical performance and excellent throughput capabilities
por: Flieder, T., et al.
Publicado: (2016)

Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression
por: Fischer, Bastian, et al.
Publicado: (2021)

Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran
por: Härtig, Florian, et al.
Publicado: (2021)

Humoral and cellular immune response levels at a 1-year follow-up after mild COVID-19
por: Flieder, Tobias, et al.
Publicado: (2022)

The Human Myofibroblast Marker Xylosyltransferase-I: A New Indicator for Macrophage Polarization
por: Ly, Thanh-Diep, et al.
Publicado: (2022)

Retrospective analysis of 426 donors of a convalescent collective after mild COVID-19
por: Flieder, Tobias, et al.
Publicado: (2021)

Effects of dabigatran and rivaroxaban on stroke severity according to the results of routine coagulation tests
por: Cho, Han-Jin, et al.
Publicado: (2020)

Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
por: Yin, Lu, et al.
Publicado: (2022)

First description of the complete human xylosyltransferase-I promoter region
por: Faust, Isabel, et al.
Publicado: (2014)

New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers
por: Hendig, Doris, et al.
Publicado: (2013)

ABCC6- a new player in cellular cholesterol and lipoprotein metabolism?
por: Kuzaj, Patricia, et al.
Publicado: (2014)

microRNA-29b mediates fibrotic induction of human xylosyltransferase-I in human dermal fibroblasts via the Sp1 pathway
por: Riedel, Lara, et al.
Publicado: (2018)

Routine Coagulation Tests in Patients With Nonvalvular Atrial Fibrillation Under Dabigatran and Rivaroxaban Therapy: An Affordable and Reliable Strategy?
por: Silva, Vanessa M., et al.
Publicado: (2019)

Strain-dependent interactions of Streptococcus gallolyticus subsp. gallolyticus with human blood cells
por: Grimm, Imke, et al.
Publicado: (2017)

Identification of Putative Non-Substrate-Based XT-I Inhibitors by Natural Product Library Screening
por: Ly, Thanh-Diep, et al.
Publicado: (2020)

Activin A-Mediated Regulation of XT-I in Human Skin Fibroblasts
por: Ly, Thanh-Diep, et al.
Publicado: (2020)

The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation
por: Richards, Guy A., et al.
Publicado: (2018)

Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins
por: Jakimczuk, Aleksandra, et al.
Publicado: (2022)

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
por: Henskens, Yvonne M. C., et al.
Publicado: (2018)

Human xylosyltransferases – mediators of arthrofibrosis? New pathomechanistic insights into arthrofibrotic remodeling after knee replacement therapy
por: Faust, Isabel, et al.
Publicado: (2015)

Retrospective study shows that early administration of convalescent plasma in hospitalized COVID‐19 patients may have a positive effect on disease progression
por: Birschmann, Ingvild, et al.
Publicado: (2022)

Large-Scaled Metabolic Profiling of Human Dermal Fibroblasts Derived from Pseudoxanthoma Elasticum Patients and Healthy Controls
por: Kuzaj, Patricia, et al.
Publicado: (2014)

Changes in the Proteome of Platelets from Patients with Critical Progression of COVID-19
por: Wolny, Monika, et al.
Publicado: (2023)

Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients
por: Lai, Chao‐Lun, et al.
Publicado: (2017)

Targeting ABCC6 in Mesenchymal Stem Cells: Impairment of Mature Adipocyte Lipid Homeostasis
por: Plümers, Ricarda, et al.
Publicado: (2022)

Matrix Metalloproteinases Contribute to the Calcification Phenotype in Pseudoxanthoma Elasticum
por: Plümers, Ricarda, et al.
Publicado: (2023)

Understanding of arthrofibrosis: New explorative insights into extracellular matrix remodeling of synovial fibroblasts
por: Ly, Thanh-Diep, et al.
Publicado: (2023)

Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants
por: Ebner, Matthias, et al.
Publicado: (2017)

Statins as a Therapeutic Approach for the Treatment of Pseudoxanthoma Elasticum Patients: Evaluation of the Spectrum Efficacy of Atorvastatin In Vitro
por: Tiemann, Janina, et al.
Publicado: (2021)

Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis
por: Ebner, Matthias, et al.
Publicado: (2018)

Quality Analysis of American Ginseng Cultivated in Heilongjiang Using UPLC-ESI(−)-MRM-MS with Chemometric Methods
por: Xia, Yong-Gang, et al.
Publicado: (2018)

Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban
por: Charlton, Blake, et al.
Publicado: (2018)

Dabigatran as an alternative for atrial thrombosis resistant to rivaroxaban: A case report
por: Sun, Huan, et al.
Publicado: (2018)

Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
por: Úlehlová, Jana, et al.
Publicado: (2021)

Point-of-care testing of coagulation in patients treated with edoxaban
por: Härtig, Florian, et al.
Publicado: (2020)

Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran – A Case Report
por: Gumbis, Gediminas, et al.
Publicado: (2023)

Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
por: Wisløff, Torbjørn, et al.
Publicado: (2014)

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
por: Chan, Yi‐Hsin, et al.
Publicado: (2018)

Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban, and Apixaban Therapy by Novel Automated Thrombelastography
por: Artang, Ramin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c9e90veoptsfnt3hkutdj827u1